Titan Pharmaceuticals
TTNP
#10793
Rank
โ‚น0.59 B
Marketcap
โ‚น445.10
Share price
-3.76%
Change (1 day)
29.68%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น423.86. In 2023 the company made an earnings per share (EPS) of -โ‚น715.45 an increase over its 2022 EPS that were of -โ‚น1,467.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น715.45-51.22%
2022-โ‚น1,467-15.61%
2021-โ‚น1,738-81.37%
2020-โ‚น9,327-77.52%
2019-โ‚น41,498-56.32%
2018-โ‚น95,008-59.51%
2017-โ‚น2,34,670-371.81%
2016โ‚น86,335-144.35%
2015-โ‚น1,94,650300%
2014-โ‚น48,663-121.54%
2013โ‚น2,25,933-151.38%
2012-โ‚น4,39,702-11.54%
2011-โ‚น4,97,054188.89%
2010-โ‚น1,72,057-10%
2009-โ‚น1,91,175
2007-โ‚น7,83,816-2.38%
2006-โ‚น8,02,934-39.13%
2005-โ‚น13,19,105-16.87%
2004-โ‚น15,86,750-22.43%
2003-โ‚น20,45,5694.9%
2002-โ‚น19,49,98261.9%
2001-โ‚น12,04,401-13.7%
2000-โ‚น13,95,57565.01%
1999-โ‚น8,45,766-35.87%
1998-โ‚น13,18,880-1824.71%
1997โ‚น76,470-102.4%
1996-โ‚น31,92,617

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.35-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น677.80-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น391.04-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น88.83-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.17-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น411.31-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA